✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹158 Cr.
P/E
36.04

Key Ratios

Market cap
Market cap
158 Cr
PE
PE
36.04
Prom Holding
Prom Holding
53.65 %
ROE (%)
ROE (%)
14.41
ROCE (%)
ROCE (%)
19.78
Div Yield (%)
Div Yield (%)
-
Sales
Sales
126 Cr
OPM (%)
OPM (%)
12.53 %
Debt to Equity
Debt to Equity
0.81

About

Lactose (India) Limited forces home one strong promise Only the best is good enough for our cu… Read more
Low
84
52W Range
High
247
  • Lactose India
  • Vaishali Pharma
  • Quest Laboratories

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Lactose (India) Ltd. Business

Lactose (India) Limited in Vadodara, Gujarat, ensures only the highest quality products leave its facility, meeting the rigorous standards set by the company and its customers.

Lactose India major competitors are Quest Laboratories, Vaishali Pharma, Krebs Biochem.&Inds, Smruthi Organics, IndoAmerican Advance, Parnax Lab, Kimia Biosciences.
Market Cap of Lactose India is ₹152 Crs.
While the median market cap of its peers are ₹154 Crs.

Lactose India seems to be less financially stable compared to its competitors.
Altman Z score of Lactose India is 3.87 and is ranked 4 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material